Invention Grant
- Patent Title: Pyrrolidinone derivatives as MetAP-2 inhibitors
-
Application No.: US15501494Application Date: 2015-07-10
-
Publication No.: US10005756B2Publication Date: 2018-06-26
- Inventor: Timo Heinrich , Frank Zenke , Felix Rohdich , Manja Friese-Hamim , Diane Hahn
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Priority: EP14002720 20140804
- International Application: PCT/EP2015/001421 WO 20150710
- International Announcement: WO2016/020031 WO 20160211
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437 ; C07D401/04 ; A61K31/4025 ; A61K31/00 ; A61K31/4015 ; C07D207/277 ; C07D401/06 ; C07D401/12 ; C07D403/04 ; C07D403/12 ; C07D405/04 ; C07D405/12 ; C07D405/14 ; C07D409/12 ; C07D413/10 ; C07D413/12
Abstract:
Compounds according to Claim 1, are inhibitors of methionine aminopeptidase and can be employed for the treatment of tumors.
Public/Granted literature
- US20170226080A1 PYRROLIDINONE DERIVATIVES AS METAP-2 INHIBITORS Public/Granted day:2017-08-10
Information query
